S 1236 Massachusetts Senate · 193rd Legislature (2023-2024)

An Act relative to benzodiazepines and non-benzodiazepine hypnotics

This bill amends Massachusetts laws regarding benzodiazepines and non-benzodiazepine hypnotics to improve patient safety and education. It requires pharmacists to include bolded warnings about long-term risks on prescription labels and to provide educational pamphlets to patients at the time of dispensing. The legislation also mandates that doctors obtain written informed consent before prescribing these drugs and limits written prescriptions to less than a ten-day supply to prevent refills. Additionally, the bill directs the Department of Public Health to create guidelines for safely tapering off these medications and establishes a nine-member commission to study safe discontinuation protocols.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
May 2024
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action May 16, 2024
Floor votes

How they voted

This bill passed the House. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
7
Key actions
3
Committee
4
May 16, 2024
Upper · Passed
Committee recommended ought to pass and referred to the committee on Senate Ways and Means
upper
Apr 16, 2024
Committee
Referred to the committee on Rules of the two branches, acting concurrently
upper
Mar 7, 2024
Upper · Passed
Bill reported favorably by committee and referred to the committee on Health Care Financing
upper
Feb 16, 2023
Lower · Passed
House concurred
lower
Feb 16, 2023
Committee
Referred to the committee on Mental Health, Substance Use and Recovery
upper
1 primary · 0 co-sponsors

Sponsors